SCUEL — Japan healthcare data

HomeTherapeutic areas › Antidiabetic agents

Japan market screening · Therapeutic class

Antidiabetic agents in Japan

糖尿病用剤 · Japan Standard Commodity Classification

39 molecules in this class are marketed in Japan across 319 products. 27 of those products are not shipping normally today — 8.5% of the class. Supply status is reported to the Ministry of Health, Labour and Welfare and updated daily.

39Molecules
319Marketed products
27Products constrained

Molecules in this class

Ordered by how many products compete. Constrained means limited supply or supply suspended; supply suspended does not mean discontinued.

MoleculeProducts CompaniesConstrained Supply mix
Glimepirideグリメピリド72233
Pioglitazone Hydrochlorideピオグリタゾン塩酸塩48163
Vogliboseボグリボース32103
Metformin Hydrochlorideメトホルミン塩酸塩24137
Miglitolミグリトール1843
Mitiglinide Calcium Hydrateミチグリニドカルシウム水和物146
Dapagliflozinダパグリフロジン126
Glibenclamideグリベンクラミド1052
Vildagliptinビルダグリプチン1010
Gliclazideグリクラジド846
Sitagliptin Phosphate Hydrateシタグリプチンリン酸塩水和物82
Vildagliptin / Metformin Hydrochlorideビルダグリプチン・メトホルミン塩酸塩63
Acarboseアカルボース42
Nateglinideナテグリニド42
Saxagliptin Hydrateサキサグリプチン水和物42
Teneligliptin Hydrobromide Hydrateテネリグリプチン臭化水素酸塩水和物41
Alogliptin Benzoateアログリプチン安息香酸塩31
Luseogliflozin Hydrateルセオグリフロジン水和物31
Trelagliptin Succinateトレラグリプチンコハク酸塩31
Alogliptin Benzoate / Pioglitazone Hydrochlorideアログリプチン安息香酸塩・ピオグリタゾン塩酸塩21
Anagliptin / Metformin Hydrochlorideアナグリプチン・メトホルミン塩酸塩21
Canagliflozin Hydrateカナグリフロジン水和物21
Empagliflozinエンパグリフロジン21
Empagliflozin / Linagliptinエンパグリフロジン・リナグリプチン21
Ipragliflozin L-Prolineイプラグリフロジン L-プロリン21
Mitiglinide Calcium Hydrate / Vogliboseミチグリニドカルシウム水和物・ボグリボース21
Omarigliptinオマリグリプチン21
Pioglitazone Hydrochloride / Glimepirideピオグリタゾン塩酸塩・グリメピリド21
Pioglitazone Hydrochloride / Metformin Hydrochlorideピオグリタゾン塩酸塩・メトホルミン塩酸塩21
Repaglinideレパグリニド21
Teneligliptin Hydrobromide Hydrate / Canagliflozin Hydrateテネリグリプチン臭化水素酸塩水和物・カナグリフロジン水和物21
Alogliptin Benzoate / Metformin Hydrochlorideアログリプチン安息香酸塩・メトホルミン塩酸塩11
Anagliptinアナグリプチン11
Imeglimin Hydrochlorideイメグリミン塩酸塩11
Insulin Degludec (Genetical Recombination) / Liraglutide (Genetical Recombination)インスリン デグルデク(遺伝子組換え)・リラグルチド(遺伝子組換え)11
Insulin Glargine (Genetical Recombination) / Lixisenatideインスリングラルギン(遺伝子組換え)・リキシセナチド11
Linagliptinリナグリプチン11
Sitagliptin Phosphate Hydrate / Ipragliflozin L-Prolineシタグリプチンリン酸塩水和物・イプラグリフロジン L-プロリン11
Tofogliflozin Hydrateトホグリフロジン水和物11
Normal supply Limited supply Supply suspended

How to read this

Products counts every marketed product across all strengths and forms, not companies. Companies is the number of companies marketing that molecule; the same company may appear under several molecules, so the column does not add up to a class total. Market size sits on each molecule's own page, valued at national price rather than transaction price. Figures are as at 2026-08-28.

Screening this area in Japan?

Tell us which molecules matter to you. We will tell you what the public data can and cannot answer before you commission anything.

Send an enquiry

Our Database Division replies in English within three business days (Japan time).